유전자 변이 분석 시장 보고서(2026년)

Genetic mutation analysis is the study and examination of changes in an organism's DNA sequence that alter its genetic code. It focuses on identifying and characterizing variations such as base substitutions, insertions, deletions, or structural rearrangements within specific genes or genomic regions. This process aims to assess the nature and potential impact of these alterations, providing insights into the patterns, diversity, and implications of genetic changes.

The main components of genetic mutation analysis include hardware, software, and services. Hardware consists of laboratory equipment used to extract, amplify, and analyze genetic material for mutation detection. It employs various technologies, including next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray, Sanger sequencing, and clustered regularly interspaced short palindromic repeats (CRISPR). Genetic mutation analysis is applied across multiple areas, such as oncology, cardiovascular diseases, neurological disorders, infectious diseases, genetic disorders, and pharmacogenomics, and serves key end users, including hospitals and clinics, research institutes, pharmaceutical and biotechnology companies, and diagnostic laboratories.

Tariffs have impacted the genetic mutation analysis market by increasing costs of imported sequencers, PCR machines, microarray instruments, and high-end software tools. Segments like hardware and advanced sequencing services are most affected, particularly in North America, Europe, and Asia-Pacific regions including China and India. This has led to higher operational costs and slowed deployment of advanced genetic testing solutions. On the positive side, tariffs have encouraged local manufacturing of instruments, development of cost-effective software, and investment in domestic bioinformatics capabilities.

The genetic mutation analysis market research report is one of a series of new reports from The Business Research Company that provides genetic mutation analysis market statistics, including genetic mutation analysis industry global market size, regional shares, competitors with a genetic mutation analysis market share, detailed genetic mutation analysis market segments, market trends and opportunities, and any further data you may need to thrive in the genetic mutation analysis industry. This genetic mutation analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The genetic mutation analysis market size has grown rapidly in recent years. It will grow from $6.65 billion in 2025 to $7.43 billion in 2026 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to limited access to advanced sequencing technologies, growing awareness of genetic disorders, increasing research in oncology and inherited diseases, adoption of pcr and microarray technologies, early development of bioinformatics tools.

The genetic mutation analysis market size is expected to see rapid growth in the next few years. It will grow to $11.47 billion in 2030 at a compound annual growth rate (CAGR) of 11.5%. The growth in the forecast period can be attributed to advancements in crispr and ngs platforms, expansion of pharmacogenomics research, rising investments in genetic testing infrastructure, integration of ai-driven data interpretation tools, increasing collaborations between research institutes and biotech companies. Major trends in the forecast period include increasing adoption of next-generation sequencing and crispr technologies, rising demand for personalized medicine and targeted therapies, expansion of genetic testing services in clinical diagnostics, integration of bioinformatics and data analysis platforms, growth in research on rare genetic disorders and pharmacogenomics.

The rising prevalence of genetic disorders is expected to drive the growth of the genetic mutation analysis market in the coming years. Genetic disorders are diseases caused by abnormalities or mutations in an individual's DNA, which may be inherited or occur spontaneously. The increase in these disorders is partly linked to advanced parental age, which raises the likelihood of genetic mutations during reproduction and consequently increases the risk of genetic disorders in offspring. Genetic mutation analysis identifies changes in genes that can cause or indicate the presence of genetic disorders, enabling early diagnosis, targeted treatments, and informed reproductive or lifestyle decisions. For example, according to the Cystic Fibrosis Trust in October 2024, the number of registered cystic fibrosis patients in the UK rose from 11,148 in 2022 to 11,318 in 2023, reflecting a 1.5% year-over-year increase in patient registrations. This growing prevalence of genetic disorders is therefore fueling the expansion of the genetic mutation analysis market.

Key companies in the genetic mutation analysis market are focusing on innovative solutions, such as tissue-based next-generation sequencing (NGS) tests, to enhance the precision of detecting actionable genetic alterations and guiding personalized treatment strategies. Tissue-based NGS tests are advanced diagnostics that analyze DNA or RNA from tissue samples to detect genetic mutations, alterations, or biomarkers associated with diseases such as cancer. For instance, in June 2024, Guardant Health Inc., a US-based oncology company, launched the Guardant360 TissueNext test, which expands the number of genes analyzed in tumor tissue samples to 498. These genes serve as cancer biomarkers, helping oncologists select the most effective targeted therapies for patients with advanced cancer. Additionally, the test features an improved operational workflow for faster turnaround times. Guardant360 TissueNext will be covered as a standalone service for Medicare fee-for-service patients with advanced solid tumors, based on coverage through Palmetto GBA under the Molecular Diagnostics Services program (MolDX).

In June 2023, Dotmatics Ltd., a US-based scientific informatics software company, acquired SoftGenetics for an undisclosed amount. This acquisition aims to enhance Dotmatics' capabilities in genomics data analysis and bioinformatics by integrating SoftGenetics' advanced genetic analysis tools, thereby strengthening its life sciences R&D platform and expanding its presence in the precision medicine and genetic research markets. SoftGenetics LLC, based in the US, specializes in bioinformatics software for mutation detection, sequencing, and forensic applications.

Major companies operating in the genetic mutation analysis market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies Plc, Genomic Health Inc., Color Genomics Inc., Blueprint Medicines Corporation, GENEWIZ Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Personalis Inc., LGC Biosearch Technologies LLC, BGI Genomics Co. Ltd.

North America was the largest region in the genetic mutation analysis market in 2025. The regions covered in the genetic mutation analysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the genetic mutation analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The genetic mutation analysis market consists of revenues earned by entities by providing services such as mutation validation, biomarker discovery, genome annotation, structural variation analysis, and epigenetic profiling. The market value includes the value of related goods sold by the service provider or included within the service offering. The genetic mutation analysis market also includes sales of DNA extraction tools, mutation detection assays, sequencing panels, and genomic reference materials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Genetic Mutation Analysis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses genetic mutation analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for genetic mutation analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The genetic mutation analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Component: Hardware; Software; Services
• 2) By Technology: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarray; Sanger Sequencing; Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
• 3) By Application: Oncology; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Genetic Disorders; Pharmacogenomics
• 4) By End User: Hospitals And Clinics; Research Institutes; Pharmaceutical And Biotechnology Companies; Diagnostic Laboratories
• Subsegments:
• 1) By Hardware: Sequencers; Polymerase Chain Reaction (PCR) Machines; Microarray Instruments; Electrophoresis Systems; Imaging Systems
• 2) By Software: Data Analysis Software; Sequence Alignment Tools; Variant Calling Software; Genome Annotation Software; Visualization Tools
• 3) By Services: Genetic Testing Services; Data Interpretation Services; Bioinformatics Services; Sample Preparation Services; Clinical Reporting Services
• Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Agilent Technologies Inc.; Illumina Inc.; Revvity Inc.; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Natera Inc.; Myriad Genetics Inc.; GenScript Biotech Corporation; Takara Bio Inc.; 10x Genomics Inc.; Oxford Nanopore Technologies Plc; Genomic Health Inc.; Color Genomics Inc.; Blueprint Medicines Corporation; GENEWIZ Inc.; Pacific Biosciences of California Inc.; Standard BioTools Inc.; Personalis Inc.; LGC Biosearch Technologies LLC; BGI Genomics Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Genetic Mutation Analysis Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Genetic Mutation Analysis Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Genetic Mutation Analysis Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Genetic Mutation Analysis Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Artificial Intelligence & Autonomous Intelligence
  • 4.1.4 Industry 4.0 & Intelligent Manufacturing
  • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Next-Generation Sequencing And Crispr Technologies
  • 4.2.2 Rising Demand For Personalized Medicine And Targeted Therapies
  • 4.2.3 Expansion Of Genetic Testing Services In Clinical Diagnostics
  • 4.2.4 Integration Of Bioinformatics And Data Analysis Platforms
  • 4.2.5 Growth In Research On Rare Genetic Disorders And Pharmacogenomics

5. Genetic Mutation Analysis Market Analysis Of End Use Industries

• 5.1 Hospitals And Clinics
• 5.2 Research Institutes
• 5.3 Pharmaceutical Companies
• 5.4 Diagnostic Laboratories
• 5.5 Academic And Genomic Research Centers

6. Genetic Mutation Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Genetic Mutation Analysis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Genetic Mutation Analysis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Genetic Mutation Analysis Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Genetic Mutation Analysis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Genetic Mutation Analysis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Genetic Mutation Analysis Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Genetic Mutation Analysis Market Segmentation

• 9.1. Global Genetic Mutation Analysis Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hardware, Software, Services
• 9.2. Global Genetic Mutation Analysis Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarray, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
• 9.3. Global Genetic Mutation Analysis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Oncology, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Genetic Disorders, Pharmacogenomics
• 9.4. Global Genetic Mutation Analysis Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals And Clinics, Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories
• 9.5. Global Genetic Mutation Analysis Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Sequencers, Polymerase Chain Reaction (PCR) Machines, Microarray Instruments, Electrophoresis Systems, Imaging Systems
• 9.6. Global Genetic Mutation Analysis Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Data Analysis Software, Sequence Alignment Tools, Variant Calling Software, Genome Annotation Software, Visualization Tools
• 9.7. Global Genetic Mutation Analysis Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Genetic Testing Services, Data Interpretation Services, Bioinformatics Services, Sample Preparation Services, Clinical Reporting Services

10. Genetic Mutation Analysis Market Regional And Country Analysis

• 10.1. Global Genetic Mutation Analysis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Genetic Mutation Analysis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Genetic Mutation Analysis Market

• 11.1. Asia-Pacific Genetic Mutation Analysis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Genetic Mutation Analysis Market

• 12.1. China Genetic Mutation Analysis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Genetic Mutation Analysis Market

• 13.1. India Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Genetic Mutation Analysis Market

• 14.1. Japan Genetic Mutation Analysis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Genetic Mutation Analysis Market

• 15.1. Australia Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Genetic Mutation Analysis Market

• 16.1. Indonesia Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Genetic Mutation Analysis Market

• 17.1. South Korea Genetic Mutation Analysis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Genetic Mutation Analysis Market

• 18.1. Taiwan Genetic Mutation Analysis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Genetic Mutation Analysis Market

• 19.1. South East Asia Genetic Mutation Analysis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Genetic Mutation Analysis Market

• 20.1. Western Europe Genetic Mutation Analysis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Genetic Mutation Analysis Market

• 21.1. UK Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Genetic Mutation Analysis Market

• 22.1. Germany Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Genetic Mutation Analysis Market

• 23.1. France Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Genetic Mutation Analysis Market

• 24.1. Italy Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Genetic Mutation Analysis Market

• 25.1. Spain Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Genetic Mutation Analysis Market

• 26.1. Eastern Europe Genetic Mutation Analysis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Genetic Mutation Analysis Market

• 27.1. Russia Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Genetic Mutation Analysis Market

• 28.1. North America Genetic Mutation Analysis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Genetic Mutation Analysis Market

• 29.1. USA Genetic Mutation Analysis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Genetic Mutation Analysis Market

• 30.1. Canada Genetic Mutation Analysis Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Genetic Mutation Analysis Market

• 31.1. South America Genetic Mutation Analysis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Genetic Mutation Analysis Market

• 32.1. Brazil Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Genetic Mutation Analysis Market

• 33.1. Middle East Genetic Mutation Analysis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Genetic Mutation Analysis Market

• 34.1. Africa Genetic Mutation Analysis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Genetic Mutation Analysis Market, Segmentation By Component, Segmentation By Technology, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Genetic Mutation Analysis Market Regulatory and Investment Landscape

36. Genetic Mutation Analysis Market Competitive Landscape And Company Profiles

• 36.1. Genetic Mutation Analysis Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Genetic Mutation Analysis Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Genetic Mutation Analysis Market Company Profiles
  • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Revvity Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Genetic Mutation Analysis Market Other Major And Innovative Companies

• Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Takara Bio Inc., 10x Genomics Inc., Oxford Nanopore Technologies Plc, Genomic Health Inc., Color Genomics Inc., Blueprint Medicines Corporation, GENEWIZ Inc., Pacific Biosciences of California Inc., Standard BioTools Inc., Personalis Inc.

38. Global Genetic Mutation Analysis Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Genetic Mutation Analysis Market

40. Genetic Mutation Analysis Market High Potential Countries, Segments and Strategies

• 40.1 Genetic Mutation Analysis Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Genetic Mutation Analysis Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Genetic Mutation Analysis Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer